10x Genomics Inc. Optimization Slides, Reagent Kits, and Reagent Delivery Methods
Closed Pre-Solicitation Posted
- Solicitation number
- 75N95024Q00448
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services' National Institutes of Health, intends to negotiate and issue a 12-month extension to an existing indefinite-delivery, indefinite-quantity (IDIQ) contract with 10X Genomics, Inc. to continue providing 10X Genomics-manufactured optimization slides, reagent kits, and reagent delivery methods. These biological technologies are used in NINDS research projects to map gene expression, transcription, and profiling for neurological diseases. Responses to this pre-solicitation notice must be received by 4:00 PM ET on July 31, 2024 and include the contractor's Unique Entity Identifier, Taxpayer Identification Number, and business size certification.
This proposed contract modification is classified under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees. There is no set-aside designation for this procurement. The existing IDIQ contract (75N95023D00018) was awarded as a result of a previous solicitation, and the proposed modification would not result in any other changes to the contract. No award value or budget range information is provided in the pre-solicitation notice.
Notice text
The purpose of this acquisition is to continue providing 10X Genomics Inc.-manufactured optimization slides, reagent kits, and reagent delivery methods to the laboratories of the National Institute of Neurological Disorders and Stroke (NINDS). Related previous and continuing research projects being conducted by NINDS laboratories have utilized the 10X Genomics Inc. reagent kits, optimization slides and other consumables in tandem with an existing 10X Genomics Inc. Chromium System. To maintain the integrity of the research data previously generated, the same reagent kits, optimization slides and consumables must be used for the ongoing and planned, follow-on research projects. These biological technologies are used to map gene expression, transcription, and profiling for neurological diseases such as Psychosis, Multiple Sclerosis, Undiagnosed neuroinflammatory diseases, and many other neurological and brain disorders. Please see the attached Presolicitation Notice for additional information.
Files
| File | Type | Posted |
|---|---|---|
| Presolicitation Notice_Noncompetitive_75N95024Q00448.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity